What are the steps in supplement manufacturing?

The core flow is dispensing and weighing components, blending them to a uniform mix, optional granulation to improve flow, forming the dose by tableting or encapsulation, coating and finishing, then packaging and labeling. Quality control runs across every step, from component identity testing through finished-product testing and quality-unit release.

Is nutraceutical manufacturing regulated like drug manufacturing?

No. Dietary supplements are regulated by FDA as a category of food, not as drugs, so they do not require premarket approval. But manufacturers must follow the dietary supplement cGMP rule, 21 CFR Part 111, which is stricter than the general food GMP and requires component identity testing, specifications, master and batch records, and a quality unit.

What is the difference between tablets, capsules, and softgels?

Tablets are compressed from a granulated or direct-compression blend on a tablet press. Two-piece hard capsules are filled with powder or granules by an encapsulator. Softgels are one-piece gelatin or plant-based shells that encapsulate a liquid or paste. The choice depends on the ingredient, the dose, stability, and the market, but all three must hit the same dose-accuracy and content-uniformity targets.

Why is component identity testing required for supplements?

Because the fastest way to make a wrong supplement is to start with the wrong ingredient. 21 CFR Part 111 requires verifying the identity of every incoming dietary-ingredient component with a scientifically valid method before use, unless FDA grants an exemption. A supplier certificate of analysis alone does not satisfy it, and failing to test identity is among the most cited Part 111 inspection findings.

What is blend uniformity in supplement manufacturing?

Blend uniformity is how evenly the active ingredient is distributed through the batch, so the last capsule or tablet matches the first. It is measured by sampling defined locations and computing relative standard deviation, and it is the heart of dose accuracy. Under-blending or segregation during transfer are the common ways it fails.

Do supplement batch records have to be electronic?

No. Part 111 requires master manufacturing records and batch production records but does not mandate that they be electronic. If a manufacturer keeps them electronically and uses electronic signatures, those systems must meet the controls in 21 CFR Part 11. Many manufacturers keep specifications, master records, and batch records in connected digital systems to speed retrieval, review, and release.

Nutraceutical and Supplement Manufacturing

Q: What is nutraceutical manufacturing?

It is the production of dietary supplements, vitamins, minerals, botanicals, amino acids, probiotics and more, into finished dosage forms such as tablets, capsules, softgels, gummies, and powders. In the United States it is regulated as a food category under FDA's dietary supplement cGMP rule, 21 CFR Part 111, which requires proof that the finished product matches its label for identity and strength.

The process looks like a food line; Part 111 sits on top of it and demands proof, batch by batch, that the product is what the label says.

Nutraceutical manufacturing is the production of dietary supplements, vitamins, minerals, botanicals, amino acids, and other ingredients, into finished dosage forms such as tablets, capsules, softgels, gummies, and powders. In the United States it is regulated as a food category under FDA's dietary supplement current good manufacturing practice rule, 21 CFR Part 111, which demands proof that the finished product is exactly what the label claims.

That last point is what separates a supplement plant from a food plant. A supplement is defined by its label, a claimed amount of a claimed ingredient, so the whole operation is built to prove identity and strength, batch by batch. This guide walks the process from raw material to bottle, then covers the Part 111 controls that sit on top of it and how to run the line so every batch is releasable.

What is nutraceutical manufacturing?

Nutraceutical manufacturing turns bulk actives and excipients into a consistent, correctly dosed finished supplement. The actives are the ingredients on the label, a vitamin, a mineral salt, a botanical extract, a probiotic strain. The excipients are the supporting materials, fillers, binders, disintegrants, flow agents, coatings, that let the actives be blended, formed, and delivered reliably. The finished form is chosen for the ingredient and the market: compressed tablets, two-piece hard capsules, softgels, gummies, effervescents, sachets, or straight powders.

Whatever the form, the operation answers two questions on every batch: is the right ingredient present at the labeled strength, and is it distributed evenly so the last capsule matches the first? Everything downstream, the process controls, the testing, the records, exists to answer those two questions with evidence rather than assurance.

What are the main process steps?

The core flow is dispensing, blending, size or form conversion, forming the dose, finishing, and packaging. Most solid-dose lines follow this backbone with variations for the format:

Dispensing and material control. Each component is identified, weighed to the batch record, and reconciled. Getting the right material in the right amount is where compliance starts.
Blending. Actives and excipients are combined to a uniform blend. This is the heart of dose accuracy, the same mixing and blending uniformity problem every dosage-form maker lives with, judged by relative standard deviation across sampled locations.
Granulation (when needed). Wet or dry granulation turns a fine powder blend into free-flowing granules that compress and flow better. Direct compression skips it when the blend already flows well.
Forming the dose. Tablet presses compress granules into tablets; encapsulators fill powder or granules into hard capsules; softgel and gummy lines use their own encapsulation and depositing equipment. This is where the dose is fixed, so weight and content controls run continuously.
Coating and finishing. Film coats aid swallowing and mask taste; enteric coats survive stomach acid to release in the intestine. Polishing, printing, and inspection follow.
Packaging and labeling. Bottling, induction sealing, desiccant, blister packing, and label and lot-code application, the last chance to catch a mislabel before it ships.

The process backbone is the same across formats; the quality controls run underneath it end to end, and nothing releases until the quality unit signs the batch record.

Format changes the hard parts. Gummies are a cooking and depositing operation with its own moisture, temperature, and active-degradation controls, and they are notoriously hard to dose evenly because the active is suspended in a hot slurry. Probiotics are counted in live organisms, so overage, moisture, and temperature across the whole line decide whether the label count survives to expiry. Botanical extracts carry the highest identity and adulteration risk of anything on the floor. The equipment may be shared, but the specifications and in-process checks are format-specific, and copying a tablet program onto a gummy line is a common way to make out-of-spec product.

What does 21 CFR Part 111 require?

Part 111 is the FDA rule that governs how supplements are manufactured, packaged, labeled, and held, and it is stricter than the general food GMP. It adds four demands on top of ordinary sanitation and process control: identity-test every incoming dietary-ingredient component, run everything to written specifications, keep a master manufacturing record and a batch production record for each batch, and give a quality unit independent authority to approve or reject. The full detail of those requirements lives in our guide to dietary supplement cGMP (21 CFR Part 111); here is what they change on the floor.

The single most consequential difference from the general food GMP (21 CFR Part 117) is component identity testing. Before use, you must verify the identity of each dietary ingredient with a scientifically valid method, a supplier's certificate of analysis alone does not satisfy it. This is where botanicals get real: the wrong species, a look-alike substitution, or an adulterated extract can pass a paper check and fail the plant. Identity testing is also the single most cited Part 111 problem in FDA inspections, which tells you where inspectors look first.

The records structure is the other big lift. The master manufacturing record (MMR) is the approved recipe and procedure for a product at a given batch size, what should happen. The batch production record (BPR) is the executed record of one actual batch, what did happen, including the specific lots, weights, in-process results, and deviations. One MMR per product and batch size; one BPR per batch. The quality unit reads the BPR against the MMR and decides whether the batch is what it was supposed to be.

A supplement line looks like a food line, but Part 111 sits on top of it: identity testing, specifications, master and batch records, and a quality unit that has to sign off before release.

How do you set up a compliant nutraceutical line?

Building a supplement operation is equal parts process engineering and records architecture. This is the order that keeps the quality system ahead of the equipment rather than bolted on later:

Write specifications first. Set identity, purity, strength, and composition specs, plus contaminant limits for heavy metals, microbes, and residues, for every component, in-process material, and finished product. Specs are the foundation everything else verifies against.
Stand up component identity testing. Choose a scientifically valid identity method for each dietary ingredient and either run it or hold a granted FDA exemption. Do not rely on the certificate of analysis alone.
Author the master manufacturing record. One approved MMR per product and batch size, with the recipe, steps, in-process controls, and sign-off points.
Validate blending and forming. Prove blend uniformity at the working fill and lock the tablet or capsule weight and content controls. Dose accuracy is decided here.
Execute batch production records. Produce each batch against the MMR and capture the real lots, weights, results, and deviations in a BPR.
Give the quality unit authority. Quality-control personnel review records and make every material-review and disposition decision independent of production. Their signature is what releases a batch.
Test the finished product and hold until released. Verify the finished dose against specification, and ship only on quality-unit sign-off.

By the numbers

The regulatory anchors for supplement manufacturing, from primary sources:

FDA regulates dietary supplement manufacturing under 21 CFR Part 111 which requires establishing specifications and verifying the identity of each incoming dietary-ingredient component before use, unless FDA grants an exemption (eCFR, 21 CFR Part 111).
Part 111 requires a master manufacturing record and a batch production record for every batch, and a quality control unit that makes all material-review and disposition decisions (FDA, cGMPs for Dietary Supplements).
Dietary supplements are regulated by FDA as a category of food, not as drugs under the Dietary Supplement Health and Education Act, so premarket approval is not required, but Part 111 manufacturing controls are (FDA, Dietary Supplement Products & Ingredients).

Where do records and machine data fit?

Part 111 is a records rule as much as a manufacturing rule. Identity results, specifications, master records, batch records, and quality-unit signatures are the evidence FDA follows through any batch, and when those live in disconnected binders and spreadsheets a single missing identity test or unsigned batch record can hold up release or draw a 483 observation. Capturing dispensing, blend results, in-process weights, and quality sign-off in one connected system keeps the chain intact and the batch releasable, the same discipline that governs any batch production operation, tightened for a regulated dose.

The operational side benefits too. A supplement line loses time the way any line does, changeovers between SKUs, press stops, coating pan faults, and those losses are invisible until they are measured. Tying line events to OEE and machine downtime at the same time you capture the batch record gives quality and operations one shared picture instead of two arguments. If you keep those records electronically, they fall under 21 CFR Part 11 for electronic records and signatures, and a proper QMS ties deviations and CAPAs back to the batch. A connected plant operating system is where the recipe, the run, and the release converge, so the record is built as the batch is made, not reconstructed after it.